Glycoproteomics in neurodegenerative diseases. - Wikidata - wikimedia - TriplyDB

Glycoproteomics in neurodegenerative diseases.

Glycoproteomics in neurodegenerative diseases.

http://www.wikidata.org/entity/Q33563387

about

Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation.Proteomics of protein post-translational modifications implicated in neurodegeneration Targeted discovery and validation of plasma biomarkers of Parkinson's disease.Modified serpinA1 as risk marker for Parkinson's disease dementia: Analysis of baseline data.Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease.Application of proteomics to cerebrovascular disease.GlycoFish: a database of zebrafish N-linked glycoproteins identified using SPEG method coupled with LC/MS Targeted mass spectrometric approach for biomarker discovery and validation with nonglycosylated tryptic peptides from N-linked glycoproteins in human plasma Differential sialylation of serpin A1 in the early diagnosis of Parkinson's disease dementia.Integrated GlycoProteome Analyzer (I-GPA) for Automated Identification and Quantitation of Site-Specific N-Glycosylation Proteomic profiling in MPTP monkey model for early Parkinson disease biomarker discovery N-glycome Profile Levels Relate to Silent Brain Infarcts in a Cohort of Hypertensives.Glycosylation and other PTMs alterations in neurodegenerative diseases: Current status and future role in neurotrauma.Glycosylation of the sodium channel β4 subunit is developmentally regulated and involves in neuritic degeneration.In-depth mapping of the mouse brain N-glycoproteome reveals widespread N-glycosylation of diverse brain proteins.Site-specific characterization and quantitation of N-glycopeptides in PKM2 knockout breast cancer cells using DiLeu isobaric tags enabled by electron-transfer/higher-energy collision dissociation (EThcD).Identification and Quantification of Protein Glycosylation

P2860

Q27311994-058146C5-452E-452A-B7DC-6ADC7830D7A7 Q28088631-D1B093B7-69EA-47CD-B578-807D343B6F1B Q30597182-0366DCDD-67E8-44DB-B9A9-1D53F259AB4C Q31096478-4CE5F5D3-325C-45FC-B59A-BBE9E1F113C3 Q34032608-1E3E84F7-0842-40A7-BFFB-D4B9DF1C20EE Q34312457-9365A7C8-9E8F-4538-A5C9-A2277D926664 Q35083499-F0631D6E-5DF8-4313-91A3-CCCDACD5A9FF Q35610651-26E9CED3-D20E-45D8-BBB0-C5FF433CB135 Q36384748-B34B0141-47B3-4986-BD0F-FA1B474D0A90 Q36587490-EF3B4EFD-FC81-4270-B4FD-D33CE8B1A731 Q36598403-8A6E49F0-8781-46AA-B7FE-60D162BE5A1F Q36836256-4D42185B-4260-48A3-A359-D1EE27802395 Q37130046-A4979788-BFCF-4A5D-A81C-EB43234B2C95 Q39354416-209FB25F-B9A2-4900-985F-72A039E86CB0 Q39711692-D526193A-0E32-4DE5-A209-880AF063A99F Q52311403-77D97E2F-0D77-4217-A654-CBDBC52B4351 Q58703048-2316B583-F517-4800-AC20-1E6B49384C60

P2860

Glycoproteomics in neurodegenerative diseases.

http://www.wikidata.org/entity/Q33563387

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Glycoproteomics in neurodegenerative diseases.

@ast

Glycoproteomics in neurodegenerative diseases.

@en

Glycoproteomics in neurodegenerative diseases.

@nl

type

label

Glycoproteomics in neurodegenerative diseases.

@ast

Glycoproteomics in neurodegenerative diseases.

@en

Glycoproteomics in neurodegenerative diseases.

@nl

prefLabel

Glycoproteomics in neurodegenerative diseases.

@ast

Glycoproteomics in neurodegenerative diseases.

@en

Glycoproteomics in neurodegenerative diseases.

@nl

P1433

Q33563387-8E40197D-FBE3-4F1F-B1BC-2FFD25D8B1BB

P1476

Q33563387-B360B050-0590-452C-A0F5-AF7D173E7952

P2093

Q33563387-0422DCDC-13C5-4A64-AABC-C0AC201E1910

Q33563387-1AEB63C9-8336-4912-9272-D2A2BA3EEAC8

Q33563387-1D8D71A7-5DCE-45E9-AA2A-21A218CFCD8F

Q33563387-25614EE7-1C50-4717-A61F-09E49CD075F6

Q33563387-4C90157B-127E-4D82-AFA2-41794D573B1B

Q33563387-5075B80F-7D22-49F1-A803-F517355E8742

Q33563387-58C01BE9-1427-4CB1-9125-63D5B8541A5A

Q33563387-8179ECFC-4BBC-4B9F-AA76-DFFC872A3EFA

Q33563387-D465A997-9257-4844-A653-788904C2B76F

Q33563387-D8607EE5-A52E-4CBD-B895-3CD6D15B68EB

P2860

Q33563387-01887A99-D057-4FB9-9477-4070F8137A00

Q33563387-0393E6C2-D9F6-4574-B155-849CF518449F

Q33563387-05329D08-1DDB-44CB-9673-51C98EA5B2B0

Q33563387-05F24267-33E3-4D46-932B-5D096096D6FF

Q33563387-064F9351-171D-4DE9-90CE-057510CEA1DA

Q33563387-09059B9F-0D3D-4A1A-BFFE-08A7CB3D57E2

Q33563387-0A448633-F2D0-4701-8129-135715A232A0

Q33563387-11D54B01-830A-4A0E-BA18-9B02D77A1C61

Q33563387-12CE9C36-9E05-402E-A7CC-0DB79D0491B2

Q33563387-12D898B2-E400-44F2-8E77-94A9E97EE56C

P304

Q33563387-08EA1501-2342-4AC6-95A2-05199C3D5D90

P31

Q33563387-E558A349-EEEB-42BB-A631-A99451B2A0F1

P356

Q33563387-7D6284AD-DF8B-4A87-9ED8-221CEFB3BBC5

P433

Q33563387-55D38219-7784-4B14-B113-4F175D011BCB

P478

Q33563387-652CE9BE-6986-44E5-B7F0-9DD7F270FAD4

P50

Q33563387-04D350E5-AF8A-40BA-B532-7361347EA01F

Q33563387-13912F52-B103-43B2-B57E-B0968E5744C0

Q33563387-67A1226A-83DE-487B-B5B2-2D9663551214

Q33563387-90995C74-34F5-4085-A3A8-3264E5103325

Q33563387-96E1A828-DDFD-41B6-8435-DFD8E962CC91

Q33563387-D4BC1828-C20A-4C87-8F0D-490D65AB1962

P577

Q33563387-51A06938-5BAE-4964-9D5E-E2AE27580CE8

P5875

Q33563387-D024445D-0EBE-4581-A19C-C4FF11B2C4F8

P698

Q33563387-D763AF2C-776F-481A-9321-18D790B93D25

P921

Q33563387-16E25663-D566-4E7F-BAF2-DEE522A408E9

P932

Q33563387-41CC27F4-31AD-410F-9648-83706E1D9BC7

P356

P1433

Mass Spectrometry Reviews

P1476

Glycoproteomics in neurodegenerative diseases.

@en

P2093

Aneeka M Hancock

http://www.w3.org/2001/XMLSchema#string

Catherine Pan

http://www.w3.org/2001/XMLSchema#string

Elaine R Peskind

http://www.w3.org/2001/XMLSchema#string

Hyejin Hwang

http://www.w3.org/2001/XMLSchema#string

Jianpeng Zhang

http://www.w3.org/2001/XMLSchema#string

Kathryn A Chung

http://www.w3.org/2001/XMLSchema#string

Marla Gearing

http://www.w3.org/2001/XMLSchema#string

Richard P Beyer

http://www.w3.org/2001/XMLSchema#string

Roger Albin

http://www.w3.org/2001/XMLSchema#string

Sheng Pan

http://www.w3.org/2001/XMLSchema#string

P2860

Human cerebrospinal fluid peptidomics

Human neuronal pentraxin II (NPTX2): conservation, genomic structure, and chromosomal localization

Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS

Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry

iTRAQ analysis of complex proteome alterations in 3xTgAD Alzheimer's mice: understanding the interface between physiology and disease

Staging of brain pathology related to sporadic Parkinson's disease

Quantitative analysis of complex protein mixtures using isotope-coded affinity tags

Neuropathologic changes in Alzheimer's disease

Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry

Lewy bodies and parkinsonism in families with parkin mutations

P304

79-125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MAS.20221

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Cyrus P Zabetian

James B Leverenz

Joseph Jankovic

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24268304

http://www.w3.org/2001/XMLSchema#string

P698

19358229

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration

P932

2799547

http://www.w3.org/2001/XMLSchema#string